Eiger BioPharmaceuticals Inc (EIGRQ)
2.552
-0.20
(-7.20%)
USD |
OTCM |
May 17, 15:32
Eiger BioPharmaceuticals Max Drawdown (5Y): 99.72% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.72% |
| March 31, 2024 | 98.98% |
| February 29, 2024 | 98.85% |
| January 31, 2024 | 98.75% |
| December 31, 2023 | 98.68% |
| November 30, 2023 | 98.60% |
| October 31, 2023 | 98.60% |
| September 30, 2023 | 98.21% |
| August 31, 2023 | 97.89% |
| July 31, 2023 | 97.89% |
| June 30, 2023 | 97.89% |
| May 31, 2023 | 97.89% |
| April 30, 2023 | 97.89% |
| March 31, 2023 | 97.89% |
| February 28, 2023 | 97.97% |
| January 31, 2023 | 97.97% |
| December 31, 2022 | 97.97% |
| November 30, 2022 | 98.01% |
| October 31, 2022 | 98.02% |
| September 30, 2022 | 98.02% |
| August 31, 2022 | 98.02% |
| July 31, 2022 | 98.02% |
| June 30, 2022 | 98.02% |
| May 31, 2022 | 98.12% |
| April 30, 2022 | 98.21% |
| Date | Value |
|---|---|
| March 31, 2022 | 98.47% |
| February 28, 2022 | 98.47% |
| January 31, 2022 | 98.47% |
| December 31, 2021 | 98.47% |
| November 30, 2021 | 98.47% |
| October 31, 2021 | 98.47% |
| September 30, 2021 | 98.47% |
| August 31, 2021 | 98.47% |
| July 31, 2021 | 98.47% |
| June 30, 2021 | 98.47% |
| May 31, 2021 | 98.47% |
| April 30, 2021 | 98.47% |
| March 31, 2021 | 98.47% |
| February 28, 2021 | 98.47% |
| January 31, 2021 | 98.47% |
| December 31, 2020 | 98.47% |
| November 30, 2020 | 98.47% |
| October 31, 2020 | 98.47% |
| September 30, 2020 | 98.47% |
| August 31, 2020 | 98.47% |
| July 31, 2020 | 98.47% |
| June 30, 2020 | 98.47% |
| May 31, 2020 | 98.47% |
| April 30, 2020 | 98.47% |
| March 31, 2020 | 98.47% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.89%
Minimum
Mar 2023
99.72%
Maximum
Apr 2024
98.38%
Average
98.47%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| AngioDynamics Inc | 82.98% |
| Pulse Biosciences Inc | 97.22% |
| Outset Medical Inc | -- |
| Allurion Technologies Inc | -- |
| Candel Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -87.90 |
| Beta (5Y) | 2.014 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 102.8% |
| Historical Sharpe Ratio (5Y) | -0.6367 |
| Historical Sortino (5Y) | -1.058 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 52.17% |